Literature DB >> 22728070

Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.

Monalisa Singh1, Nader H Moniri.   

Abstract

The β2-adrenergic receptor (β2AR) is the prototypical member of the heptahelical G protein-coupled receptor (GPCR) superfamily and is well-known to elicit biological effects through both G protein-dependent and G protein-independent signaling cascades. Agonism of β2AR has been described to promote phosphorylation and activation of extracellular signal-regulated kinases (ERK1/2) via a G-protein/PKA pathway that transpires rapidly upon receptor agonism, as well as by a distinct β-arrestin-mediated pathway that occurs at later time points. We have previously shown that β2AR agonism promotes generation of intracellular reactive oxygen species (ROS) and that β2AR-associated G protein signaling is dependent on ROS formation. It has also been suggested that β2AR-mediated ROS generation occurs via recruitment of β-arrestins. In this study, we confirm the effects of β-arrestin on β2AR-induced ROS generation, and investigate the ROS-dependency of β-arrestin-linked β2AR signaling. In HEK293 cells, both coimmunoprecipitation and BRET studies reveal that ROS are vital for the physical interaction of β2AR with β-arrestin partner proteins. Using phosphorylation of ERK1/2 as a functional endpoint to assess the role of ROS in β2AR-β-arrestin signaling, our results show that inhibition of intracellular ROS abrogates both the β-arrestin and G protein-mediated phosphorylation of ERK1/2 upon agonism of β2AR. Importantly, both the G protein and β-arrestin components were reversed upon exogenous administration of ROS, suggesting a critical role for oxidants in stabilization of β2AR. Taken together, our data signify that ROS serve purposeful roles in stabilizing both G protein- and β-arrestin-mediated β2AR signaling in HEK293 cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728070     DOI: 10.1016/j.bcp.2012.06.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2.

Authors:  Ilya S Senatorov; Ameneh Cheshmehkani; Rebecca N Burns; Kirti Singh; Nader H Moniri
Journal:  Mol Pharmacol       Date:  2020-03-04       Impact factor: 4.436

2.  Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Authors:  Neha Milind Chitre; Bo Jarrett Wood; Azizi Ray; Nader H Moniri; Kevin Sean Murnane
Journal:  Neuropharmacology       Date:  2020-01-27       Impact factor: 5.250

Review 3.  The β2-adrenergic receptor-ROS signaling axis: An overlooked component of β2AR function?

Authors:  Kalyn M Rambacher; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2019-11-05       Impact factor: 5.858

4.  Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Authors:  Rebecca N Burns; Monalisa Singh; Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2014-01-08       Impact factor: 5.858

5.  Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension.

Authors:  Wei Chen; De-Jun Liu; Yan-Miao Huo; Zhi-Yong Wu; Yong-Wei Sun
Journal:  Int J Biol Sci       Date:  2014-03-15       Impact factor: 6.580

6.  Cysteine redox state regulates human β2-adrenergic receptor binding and function.

Authors:  Kalyn M Rambacher; Nader H Moniri
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

Review 7.  Adrenergic and Glucocorticoid Receptors in the Pulmonary Health Effects of Air Pollution.

Authors:  Myles X Hodge; Andres R Henriquez; Urmila P Kodavanti
Journal:  Toxics       Date:  2021-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.